The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded an indefinite delivery contract vehicle to Quest Diagnostics Incorporated for tuberculosis testing services. Under a single award contract with a potential value of $376,125 and period of performance through July 2025, Quest Diagnostics was issued four firm fixed price delivery orders totaling approximately $262,000 to provide Oxford Immunotec T-SPOT TB testing. Tests were to be performed in New Jersey, Louisiana, and New York from 2020 to 2025 in support of tuberculosis screening and diagnosis among veterans within the network's healthcare system. No set-aside provisions were applied. As the largest clinical laboratory provider, Quest Diagnostics will utilize its expertise in tuberculosis diagnostics to meet the Veterans Health Administration's disease prevention goals under this contract.
The original April 2020 pre-solicitation notice indicated the Department of Veterans Affairs VISN 16's intent to competitively procure tuberculosis testing for the New Orleans VAMC via a simplified commercial acquisition procedure. The estimated $60,000 single award contract was anticipated to support tuberculosis screening necessary for the veteran patient population served by the facility.
Generated 1/5/24, 9:13 PM